Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Arboviral Encephalitis01:25

Arboviral Encephalitis

59
Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
59

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A new mRNA antigen vaccine induces potent B and T cell responses and in vivo protection against SARS-CoV-2.

NPJ vaccines·2026
Same author

A new mRNA antigen vaccine induces potent B and T cell responses and <i>in vivo</i> protection against SARS-CoV-2.

bioRxiv : the preprint server for biology·2026
Same author

Structure of a SARS-CoV-2 spike S2 subunit in a pre-fusion, open conformation.

Cell reports·2025
Same author

Structural stabilization of the intrinsically disordered SARS-CoV-2 N by binding to RNA sequences engineered from the viral genome fragment.

Nature communications·2025
Same author

Enhanced durability of a Zika virus self-amplifying RNA vaccine through combinatorial OX40 and 4-1BB agonism.

JCI insight·2025
Same author

Zika but not Dengue virus infection limits NF-κB activity in human monocyte-derived dendritic cells and suppresses their ability to activate T cells.

Nature communications·2025
Same journal

Tracking Synthetic Adhesins on Bacterial Surfaces with Immunofluorescence Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

High-Performance Computing in Tandem Mass Spectrometry (MS/MS) Peptide Identification.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Engineering and Adapting Disulfide-Containing Proteins to Enable Intracellular Functionality.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

AI-Driven Protein Research: From Prediction to Design.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for the In Vitro Selection of Protein and Peptide Libraries Using mRNA Display.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: May 1, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

6.4K

Animal models in dengue.

Emily Plummer1, Sujan Shresta

  • 1Division of Vaccine Discovery, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, CA, 92037, USA.

Methods in Molecular Biology (Clifton, N.J.)
|April 4, 2014
PubMed
Summary
This summary is machine-generated.

This article details standardized methods for verifying dengue virus infection in laboratory mice. Researchers describe a precise technique to measure viral genetic material in blood and organs, alongside a visual staining approach to confirm active viral protein production within tissues. These protocols help ensure that animal models accurately reflect human disease progression.

Keywords:
viral replicationimmunohistochemistrypathogenesisviremia detection

Frequently Asked Questions

More Related Videos

Protocol for Dengue Infections in Mosquitoes A. aegypti and Infection Phenotype Determination
15:25

Protocol for Dengue Infections in Mosquitoes A. aegypti and Infection Phenotype Determination

Published on: July 4, 2007

21.4K
Establishing Mouse Models for Zika Virus-induced Neurological Disorders Using Intracerebral Injection Strategies: Embryonic, Neonatal, and Adult
09:39

Establishing Mouse Models for Zika Virus-induced Neurological Disorders Using Intracerebral Injection Strategies: Embryonic, Neonatal, and Adult

Published on: April 26, 2018

8.1K

Related Experiment Videos

Last Updated: May 1, 2026

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease
04:23

A Murine Model of Dengue Virus-induced Acute Viral Encephalitis-like Disease

Published on: April 28, 2019

6.4K
Protocol for Dengue Infections in Mosquitoes A. aegypti and Infection Phenotype Determination
15:25

Protocol for Dengue Infections in Mosquitoes A. aegypti and Infection Phenotype Determination

Published on: July 4, 2007

21.4K
Establishing Mouse Models for Zika Virus-induced Neurological Disorders Using Intracerebral Injection Strategies: Embryonic, Neonatal, and Adult
09:39

Establishing Mouse Models for Zika Virus-induced Neurological Disorders Using Intracerebral Injection Strategies: Embryonic, Neonatal, and Adult

Published on: April 26, 2018

8.1K

Area of Science:

  • Virology research within dengue virus infection models
  • Molecular diagnostics and quantitative assay development

Background:

No prior work had resolved the exact requirements for confirming viral replication in murine hosts. Researchers often struggle to validate infection models due to inconsistent detection of pathogen levels. It was already known that successful modeling requires clear evidence of systemic spread. That uncertainty drove the need for standardized verification techniques. Prior research has shown that viremia serves as a primary indicator of disease establishment. However, specific protocols for quantifying these markers remain sparse in current literature. This gap motivated the development of reliable detection strategies for laboratory settings. Establishing these benchmarks allows for more consistent evaluation of potential therapeutic interventions.

Purpose Of The Study:

The aim of this work is to establish standardized methods for validating dengue virus infection in mouse models. Researchers address the challenge of confirming productive viral replication within host tissues. This effort seeks to provide clear benchmarks for verifying systemic disease establishment. The team identifies a need for precise quantification of viral genetic material in blood. They also describe a visual approach to confirm protein production in organs. This study provides a framework for ensuring that animal models accurately represent human infection. By standardizing these procedures, the authors intend to improve the reproducibility of experimental results. The motivation lies in creating a reliable foundation for future pathogenesis and drug efficacy studies.

Main Methods:

Review approach focuses on established protocols for verifying viral presence in laboratory animals. Investigators detail a procedure for isolating and measuring genetic sequences from serum samples. The team utilizes specific probes to quantify pathogen concentration across various organ systems. Review approach also covers a fluorescence-based staining technique for identifying intracellular viral components. This visual strategy targets nonstructural markers to confirm active replication cycles. Researchers describe the preparation of tissue sections for microscopic examination. The analysis emphasizes the importance of standardized sample handling to ensure accurate results. This systematic overview provides clear instructions for implementing these diagnostic tools.

Main Results:

Key findings from the literature demonstrate that viremia verification is essential for confirming successful infection. The data indicate that quantitative assays reliably detect viral genetic material in both blood and tissue samples. Researchers report that fluorescence immunohistochemistry effectively highlights nonstructural protein localization within infected cells. These results confirm that the virus undergoes productive replication in the mouse host. The study shows that combining these two methods provides a comprehensive validation of the animal model. Findings suggest that consistent detection levels are achievable through these standardized procedures. The literature indicates that these metrics correlate with established disease progression markers. This evidence supports the utility of these techniques for rigorous model characterization.

Conclusions:

The authors propose that these standardized protocols improve the reliability of murine dengue research. Synthesis and implications suggest that quantifying genetic material provides a robust metric for infection status. Visualizing specific proteins confirms that the pathogen actively replicates within host cells. These combined approaches offer a comprehensive framework for validating experimental models. Researchers can utilize these techniques to ensure consistent disease progression across different studies. The findings imply that rigorous verification is necessary for translating animal data to human clinical contexts. Adopting these methods may reduce variability in future investigations of viral pathogenesis. This work provides a foundation for more accurate assessment of host-pathogen interactions.

The researchers propose a dual-verification strategy. They quantify viral genetic material in blood and organs while using fluorescence immunohistochemistry to visualize nonstructural protein production within host tissues. This confirms both systemic spread and active intracellular replication.

The authors utilize fluorescence immunohistochemistry to detect specific nonstructural proteins. This tool allows investigators to localize viral presence within cellular structures, providing visual confirmation of active replication that simple blood tests might overlook.

A quantitative assay is necessary to determine viral RNA levels. This technical requirement ensures that researchers can distinguish between transient exposure and productive, sustained replication within the host organism.

The authors employ viral RNA as a critical data type. This component serves as a direct indicator of viremia, allowing for precise measurement of the pathogen load in serum samples.

The researchers measure the presence of nonstructural proteins. This phenomenon indicates that the virus has successfully hijacked host machinery to produce its own components, confirming the model is biologically active.

The authors state that these protocols improve model consistency. They imply that standardized verification is a prerequisite for reliable drug testing and pathogenesis studies in future research.